OptimizeRx Corp. Announces Board and Executive Changes
Ticker: OPRX · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1448431
| Field | Detail |
|---|---|
| Company | Optimizerx CORP (OPRX) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation, board-of-directors
Related Tickers: OPRX
TL;DR
OptimizeRx shakes up board & exec comp. New faces, new pay plans.
AI Summary
OptimizeRx Corp. announced on March 10, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory plans. Specific details regarding the individuals involved and the financial implications of these changes are outlined within the report.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect company strategy and performance.
Key Players & Entities
- OptimizeRx Corp. (company) — Registrant
- March 10, 2025 (date) — Date of Report
- Nevada (jurisdiction) — State of incorporation
- 001-38543 (identifier) — SEC File Number
- 26-1265381 (identifier) — IRS Employer Identification No.
- 260 Charles Street, Suite 302, Waltham, MA 02453 (address) — Principal executive offices
FAQ
What specific items are being reported under the 8-K filing?
The filing reports on the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; and Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is OptimizeRx Corporation.
In which state was OptimizeRx Corporation incorporated?
OptimizeRx Corporation was incorporated in Nevada.
What is the address of OptimizeRx Corporation's principal executive offices?
The address of OptimizeRx Corporation's principal executive offices is 260 Charles Street, Suite 302, Waltham, MA 02453.
What is the SEC file number for OptimizeRx Corporation?
The SEC file number for OptimizeRx Corporation is 001-38543.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding OptimizeRx Corp (OPRX).